Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reissue Patent
2007-09-18
2007-09-18
Pak, Michael (Department: 1646)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
Reissue Patent
active
11324118
ABSTRACT:
The invention provides polypeptides and polynucleotides encoding a novel chemokine receptor, CCX CKR. The invention further provides reagents and methods for identifying agents that modulate the activity or expression of the receptors, as well as methods for detecting receptor expression.
REFERENCES:
patent: 5194596 (1993-03-01), Tischer et al.
patent: 5350836 (1994-09-01), Kopchick et al.
patent: 5932445 (1999-08-01), Lal et al.
patent: 6110695 (2000-08-01), Gunn et al.
patent: 6699677 (2004-03-01), Schall et al.
patent: 6835547 (2004-12-01), Gosling et al.
patent: 6998239 (2006-02-01), Gosling et al.
patent: 2001/0016336 (2001-08-01), Ellis
patent: 0 899 332 (1999-03-01), None
patent: WO 99/24463 (1999-05-01), None
patent: WO 99/33876 (1999-07-01), None
patent: WO 99/52945 (1999-10-01), None
patent: WO 00/26369 (2000-05-01), None
patent: WO 00/64941 (2000-11-01), None
patent: WO 01/27146 (2001-04-01), None
Baggiolini, M. “Chemokines in pathology and medicine.” Journal Internal Medicine, 2001, pp. 91-104, vol. 250.
Bejamiin et al., “A plasticity window for blood vessel remodeling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF,” Development, 125:1591-1598 (1998).
Bork, Peer et al; Go hunting in sequence databases but watch out for the traps;Trends in Genetics; Oct. 1996; pp. 425-427; vol. 12, No. 10.
Bork, Peer; Powers and Pitfalls in Sequence Analysis: The 70% Hurdle;Genome Research; 2000; pp. 398-400; vol. 10.
Brenner, Steven E.; Errors in genome annotation;Trends in Genetics; Apr. 1999; pp. 132-133; vol. 15, No. 4.
Creighton, T.E. (editor),Protein structure a practical approach, pp. 184-185, Information Press Ltd., Oxford, England (1990).
Dairaghi, Daniel J.;, et al. Chemokine Receptor CCR3 Function is Highly Dependent on Local pH and Ionic Strength; The Journal of Biological Chemistry; Nov. 7, 1997; pp. 28206-28209; vol. 272, No. 45.
Dairaghi, Daniel J. et al.; HHV8-encoded vMIP-I Selectively Engages Chemokine Receptor CCR8; The Journal of Biological Chemistry; Jul. 30, 1999; pp. 21569-21574; vol. 274, No. 31.
Database EMBL Accession No. Y30125; Oct. 14, 1999.
Database EMBL Accession No. Q9NPB9; Oct. 1, 2000.
Doerks, Tobias, et al.; Protein annotation: detective work for function prediction;Trends in Genetics; Jun. 1998; pp. 248-250; vol. 14, No. 6.
GenBank Accession No. AA215577; Aug. 13, 1997.
GenBank Accession No. AF233281; May 22, 2000.
GenBank Accession No. AI131555; Oct. 26, 1998.
GenBank Accession No. AI769466; Jun. 28, 1999.
GenBank Accession No. AR003970; Dec. 10, 1998.
GenBank Accession No. AW190975; Nov. 22, 1999.
GenBank Accession No. E12852; Jun. 24, 1998.
GenBank Accession No. H67224; Oct. 27, 1995.
Gosling, Jennifa, et al; Cutting Edge: Identification of a Novel Chemokine Receptor That Binds Dendritic Cell-and T Cell-Active Chemokines Including ELC, SLC, and TECK; The Journal of Immunology; 2000; pp. 2851-2856.
Hulme, E.C., editor; Receptor-Ligand Interactions A Practical Approach; 1992; Preface, Table of Contents, Chapters 6,7, 8 and 9; pp. viii-xv and 213-263; IRL Press at Oxford University Press Inc., New York, New York.
Khoja, Hamiduddin, et al.; Cloning of CCRL1, an orphan seven transmembrane receptor related to chemokine receptors, expressed abundantly in the heart;Gene; 2000; pp. 229-238, vol. 246.
Massague et al., “The TGF-beta family of growth and differential factors,”Cell, 49:437-438 (1987).
Matsuoka, Ichiro et al.; Identification of Novel Members of G-Protein Coupled Receptor Superfamily Expressed in Bovine Taste Tissue; Biochemical and Biophysical Research Communications; Jul. 15, 1993; pp. 504-511; vol. 194, No. 1.
Murphy, P. “International Union of Pharmacology. XXX. Update on Chemokine Receptor Nomenclature” Pharmacological Reviews, 2002, pp. 227-229, vol. 54, USA.
Ngo, J. Thomas, et al; Computational Complexity, Protein Structure Prediction, and the Levinthal Paradox;The Protein Folding Problem and Tertiary Structure Prediction, K. Merz, Jr. and S. LeGrand, Editors; 1994; pp. 491-495; Birkhauser, Boston.
O'Dowd, Brian F., et al.; A novel gene codes for a putative G protein-coupled receptor with an abundant expression in brain; FEBS Letters 1996; pp. 325-329.
Pilbeam et al., “Comparison of the effects of various lengths of synthetic human parathyroid hormone-related peptide (hPTHrP) of malignancy on resorption and formation in organ culture,”Bone, 14:717-720 (1993).
Schweickart et al.., “CCR11 is a Functional Receptor for the Monocyte Chemoattractant Protein Family of Chemokines,”J. Biological Chemistry, 275(13):9550-9556 (2000).
Sissors et al., “A Homogeneous Receptor Binding Assay for HTS on FlashPlate® Plus; NEN®” Life Science Products, Inc. pp. 1-7 (1999).
Skolnick, Jeffrey, et al; From gene to protein structure and function: novel applications of computational approaches in the genomic era;Trends in Biotech; 2000; pp. 34-39; vol. 18, No. 1.
Smith, Temple F., et al; The challenges of genome sequence annotation o “The devil is in the details”;Nature Biotechnology; Nov. 1997; p1. 1222-1223; vol. 15.
Townson, Jane R., et al.; Characterization of mouse CCX-CKR, a receptor for the lymphocyte-attracting chemokines TECK/mCCL25, SLC/mCCL21 and MIP-3β/mCCL 19: comparison to human CCX-CKR;Eur. J. Immunol; 2002; pp. 1230-1241; vol. 32.
Vukicevic et al., “Induction of nephrogenic mesenchyme by osteogenic protein 1 (bone morphogenetic protein 7),”PNAS,93:9021-9026 (1996).
Wells, James A.; Additivity of Mutational Effects in Proteins;Biochemistry; Sep. 18, 1990; pp. 8509-8517; vol. vol. 29, No. 37.
Yoshida et al., “Molecular Cloning of a Novel Human CC Chemokine EBI1-ligand Chemokine That is a Specific Functional Ligand for EBI1, CCR7,”J. Biol. Chem., 272(21): 13803-13809 (1997).
Yoshida et al., “Secondary Lymphoid-tissue Chemokine is a Functional Ligand for the CC Chemokine Receptor CCR7,”J. Biol. Chem., 273(12): 7118-7122 (1998).
Youn et al., “TECK, an Efficacious Chemoattractant for Human Thymocytes, Uses GPR-9-6/CCR9 as a Specific Receptor,”Blood, 94(7): 2533-2536 (1997).
Zaballos et al., “Cutting Edge: Identification of the Orphan Chemokine Receptor GPR-9-6 as CCR9, the Receptor for the Chemokine TECK,”J. Immunol., 162(10): 5671-5675 (1999).
Dairaghi Daniel J.
Gosling Jennifa
Hanley Michael
Miao Zhenhua
Schall Thomas J.
ChemoCentryx, Inc.
Pak Michael
Townsend and Townsend / and Crew LLP
LandOfFree
Methods for identifying modulators of CCX CKR activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for identifying modulators of CCX CKR activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for identifying modulators of CCX CKR activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3726430